OraSure Technologies, Inc.
NASDAQ:OSURMedical - Instruments & Supplies
-$0.16 today
- Market cap
- $247.88M
- Beta
- 1.01
- P/E (TTM)
- -4.0
- EPS (TTM)
- -$1.08
Volume 0.49M
Average 0.61M
OSUR Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
OraSure Technologies, Inc.NASDAQ: OSUR
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $913K (cash outflow) rose 117.4% year over year, ahead of the +77.8% change in trailing-twelve-month capital expenditures. Sequentially, it fell 1.0% from the prior quarter. Over 3 fiscal years it compounded at -96.0% a year.
Context
- Capital expenditures amounted to 0.0% of revenue in FY2025, down 2.0 pp from a year earlier.
- Capital expenditures grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +117.4% holds above the trailing-twelve-month pace of +77.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (4.2K) USD
- Year-over-year change
- +99.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.2K) | +99.9% |
| FY2024 | 2024-12-31 | (3.8M) | +63.1% |
| FY2023 | 2023-12-31 | (10.3M) | +83.9% |
| FY2022 | 2022-12-31 | (63.91M) | -32.8% |
| FY2021 | 2021-12-31 | (48.12M) | — |
Capital Expenditures vs competitors
How OSUR compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +77.8% is the 2nd highest of 7, against a peer median of -46.9%.
- Capital expenditures amounts to 4.1% of revenue for OSUR, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $14.95M USD | -70.1% | +248.2% | 2419.3% | |
| LTM Mar 2026 | $4.69M USD | +77.8% | -96.0% | 4.1% | |
| LTM Mar 2026 | $1.57M USD | -7.4% | -18.1% | — | |
| LTM Mar 2026 | €1.32M EUR | -65.8% | -63.4% | 8.1% | |
| LTM Mar 2026 | $779K USD | -40.5% | -37.4% | 0.5% | |
| LTM Mar 2026 | $317K USD | +85.4% | -23.2% | 0.8% | |
| LTM Mar 2026 | $208K USD | — | -68.0% | 0.2% | |
| LTM Mar 2026 | $179.08K USD | — | — | 0.9% | |
| LTM Mar 2026 | $50K USD | -53.3% | -7.8% | — | |
| LTM Mar 2026 | $8 USD | — | — | — | |
| Peer median (excluding OSUR) | — | -46.9% | -23.2% | 0.9% | |
Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (23M) | (17.93M) | 53.66M | (19.5M) | (68.73K) |
| Depreciation & Amortization | 12.5M | 15.54M | 20.94M | 10.87M | 10.19K |
| Deferred Income Tax | 1.03M | (1.65M) | 102K | (657K) | (103) |
| Stock-Based Compensation | 7.81M | 11.62M | 10.73M | 11.92M | 10.15K |
| Change in Working Capital | (38.44M) | (70.56M) | 45.76M | 18.82M | (6.8M) |
| Accounts Receivables | (6.45M) | (25.16M) | 31.12M | 15.87M | 1.95M |
| Inventory | (27.94M) | (43.05M) | 48.23M | 13.1M | 3.56M |
| Accounts Payables | 3.23M | 3.96M | (26.98M) | (7.58M) | (1.72M) |
| Other Working Capital | (7.28M) | (6.32M) | (6.61M) | (2.57M) | (10.59M) |
| Other Non-Cash Items | 4.72M | 15.79M | 10.4M | 5.92M | 6.8M |
| Operating Cash Flow | (35.38M) | (47.2M) | 141.58M | 27.37M | (49.02K) |
| Capital Expenditures | (48.12M) | (63.91M) | (10.3M) | (3.8M) | (4.2K) |
| Acquisitions (Net) | 0 | 121K | 0 | (5.04M) | (3.61K) |
| Purchases of Investments | (25.82M) | (22.87M) | (74.65M) | (53.24M) | 0 |
| Sales of Investments | 67.93M | 47.42M | 102.44M | 53.05M | 0 |
| Other Investing Activities | 513K | 60.33M | 48.67M | (30M) | 1K |
| Investing Cash Flow | (5.5M) | 21.09M | 66.15M | (39.03M) | (6.81K) |
| Debt Repayment | (686K) | (1.38M) | (1.35M) | (842K) | (61K) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.11M) | (2.25M) | (1.9M) | (3.55M) | (15.04M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (18K) | (193K) | 223K | 214K | 15.08M |
| Financing Cash Flow | (2.82M) | (3.83M) | (3.02M) | (4.18M) | (16.94K) |
| Effect of Forex Changes | (340K) | (2.84M) | 1.71M | (6.82M) | 4.29K |
| Net Change in Cash | (44.04M) | (32.78M) | 206.43M | (22.64M) | (68.49K) |
| Free Cash Flow | (83.5M) | (111.11M) | 131.28M | 23.58M | (53.22K) |
OraSure Technologies, Inc.
NASDAQ:OSUR
Intrinsic Alpha fair value
Locked
Current Price
$3.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.